Buyer profile
Iris-achats
BE- Awards
- 8
- Total awarded value
- —
- Countries
- Belgium
- Latest award
- Jan 12, 2024
- Expiring within 12 months
- 0
Award history
| Date | Vendor | Title | Category | Value | Country | Expires | Source |
|---|---|---|---|---|---|---|---|
| 01/12/2024 | GE HEALTHCARE | Belgium – Ultrasonic unit – Echografie-scanners voor verschillende medische disciplines | — | — | BE | — | View on TED ↗ |
| 12/26/2023 | GE HEALTHCARE | Belgium – Imaging equipment for medical, dental and veterinary use – Levering, ingebruikname en onderhoud van een mammografie-unit en een mini-chirurgische C-boog | — | — | BE | — | View on TED ↗ |
| 12/26/2023 | GE HEALTHCARE | Belgium – Ultrasonic unit – Echografie-scanners voor verschillende medische disciplines | — | — | BE | — | View on TED ↗ |
| 12/08/2023 | Canon Medical Systems Belgium SA | Belgium – Imaging equipment for medical, dental and veterinary use – Levering, ingebruikname en onderhoud van een mammografie-unit en een mini-chirurgische C-boog | — | — | BE | — | View on TED ↗ |
| 12/08/2023 | GE HEALTHCARE | Belgium – Ultrasonic unit – Echografie-scanners voor verschillende medische disciplines | — | — | BE | — | View on TED ↗ |
| 12/04/2023 | GE HEALTHCARE | Belgium – Ultrasonic unit – Echografie-scanners voor verschillende medische disciplines | — | — | BE | — | View on TED ↗ |
| 10/20/2023 | NOVARTIS PHARMA NV | Belgium – Pharmaceutical products – Everolimus farmaceutische specialiteiten, erenumab, indacaterol/mometason, secukinumab, deferoxamine (mesilaat), indacaterol/glycopyrronium (bromide)/mometason, sacubitril/valsartan, vildagliptine/metformine (hydrochloride), vildagliptine, canakinumab, ruxolitinib (fosfaat), ribociclib, ranibizumab, siponimod, trametinib (dimethylsulfoxide), methylergometrine (maleaat), … | — | — | BE | — | View on TED ↗ |
| 10/16/2023 | Belgium – Pharmaceutical products – Farmaceutische specialiteiten op basis van paliperidon (palmitaat), risperidon, etravirine, rilpivirine (hydrochloride), ustekinumab, decitabine, darunavir (ethanolaat)/cobicistat, ibrutinib, guselkumab, daratumumab, selexipag, esketamine en apalutamide | — | — | BE | — | View on TED ↗ |